Jack R. Reifert, Ph.D.
Affiliations: | 2011 | Molecular, Cellular & Developmental Biology | University of California, Santa Barbara, Santa Barbara, CA, United States |
Google:
"Jack Reifert"Mean distance: 16440.9 (cluster 11)
Parents
Sign in to add mentor| Stuart Feinstein | grad student | 2011 | UC Santa Barbara | |
| (Dramatic Fragmentation Without Increased Phosphorylation of Tau Precedes Amyloid Beta Mediated Neuronal Cell Death: Implications for Alzheimer's Disease Pathogenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ballew JT, Reifert JR, Daugherty PS. (2018) Antibody Biomarker Discovery Via In Vitro Evolution of Peptides. Methods in Molecular Biology (Clifton, N.J.). 1785: 249-268 |
| Pantazes RJ, Reifert J, Bozekowski J, et al. (2016) Identification of disease-specific motifs in the antibody specificity repertoire via next-generation sequencing. Scientific Reports. 6: 30312 |
| Benbow SJ, Cook BM, Reifert J, et al. (2015) Effects of Paclitaxel and Eribulin in Mouse Sciatic Nerve: A Microtubule-Based Rationale for the Differential Induction of Chemotherapy-Induced Peripheral Neuropathy. Neurotoxicity Research |
| Shropshire TD, Reifert J, Rajagopalan S, et al. (2014) Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro. Biological Chemistry. 395: 109-18 |
| Reifert J, Hartung-Cranston D, Feinstein SC. (2011) Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation. The Journal of Biological Chemistry. 286: 20797-811 |
| Leoni LM, Niemeyer C, Bendall H, et al. (2004) SDX-105 (Treanda™), Active in Non-Hodgkin’s Lymphoma Cells, Induces the Mitotic Catastrophe Death Pathway. Blood. 104: 4593-4593 |
| Leoni LM, Crain B, Bailey B, et al. (2004) Mechanism of Action and Safety of Second Generation Analogs of SDX-101 (R-Etodolac). Blood. 104: 3411-3411 |